Table 3 Patient characteristics
From: Efficient mutation screening for cervical cancers from circulating tumor DNA in blood
Entire cohort | 24 |
|---|---|
Histology | |
Squamous cell carcinoma | 19 (79%) |
Endocervical adenocarcinoma | 2 (8%) |
Small cell neuroendocrine carcinoma | 1 (4%) |
Low-grade squamous intraepithelial neoplasia | 1 (4%) |
Invasive cervical cancer | 1 (4%) |
Pathogenic stage | |
Stage I | 6 (25%) |
Stage II | 11 (46%) |
Stage III | 3 (13%) |
Stage IV | 4 (17%) |